GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (FRA:7CA) » Definitions » Forward PE Ratio

Camurus AB (FRA:7CA) Forward PE Ratio : 105.26 (As of Apr. 29, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Camurus AB Forward PE Ratio?

Camurus AB's Forward PE Ratio for today is 105.26.

Camurus AB's PE Ratio without NRI for today is 65.42.

Camurus AB's PE Ratio for today is 65.42.


Camurus AB Forward PE Ratio Historical Data

The historical data trend for Camurus AB's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Forward PE Ratio Chart

Camurus AB Annual Data
Trend 2022-12 2023-12 2024-04
Forward PE Ratio
29.94 50.76 103.09

Camurus AB Quarterly Data
2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03
Forward PE Ratio 28.74 29.94 27.78 33.44 36.36 50.76 109.89

Competitive Comparison of Camurus AB's Forward PE Ratio

For the Biotechnology subindustry, Camurus AB's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's Forward PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Camurus AB's Forward PE Ratio falls into.



Camurus AB Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Camurus AB  (FRA:7CA) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Camurus AB Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Camurus AB's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB (FRA:7CA) Business Description

Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.

Camurus AB (FRA:7CA) Headlines

No Headlines